Table 2.
Group D (n=36) | Group S (n=34) | P-value | |
---|---|---|---|
| |||
Hypotension | 0 | 0 | 1 |
Pruritus | 0 | 1 (2.9%) | 0.131 |
Nausea and vomiting | 1 (2.7%) | 3 (8.8%) | 0.122 |
Maternal bradycardia | 0 | 0 | 1 |
Fetal bradycardia | 3 (8.3%) | 2 (5.8%) | 0.506 |
Respiratory depression | 0 | 0 | 1 |
Shivering | 2 (5.5%) | 3 (8.8%) | 0.371 |
Excessive sedation | 0 | 0 | 1 |
Notes: Data were presented as n (%). Group D received 0.5 µg/mL dexmedetomidine with 0.1% ropivacaine for epidural labor analgesia, and group S (control group) received 0.5 µg/mL sufentanil with 0.1% ropivacaine for labor analgesia.